Emerging drug therapies in Huntington's disease.

Abstract

Huntington's disease (HD) is a relentless neurodegenerative disease that results in profound disability through a triad of motor, cognitive and neuropsychiatric symptoms. At present, there are very few therapeutic interventions available with the exception of a limited number of drugs that offer mild symptomatic relief. Although the genetic basis of the… (More)
DOI: 10.1517/14728210902918299

Topics

2 Figures and Tables

Cite this paper

@article{Mason2009EmergingDT, title={Emerging drug therapies in Huntington's disease.}, author={Sarah L. Mason and Roger A. Barker}, journal={Expert opinion on emerging drugs}, year={2009}, volume={14 2}, pages={273-97} }